At Biofourmis, our mission is clear: we are augmenting personalized care with Prescription Digital Therapeutics. Founded and headquartered in Singapore, we discover, develop and deliver clinically- validated software-based therapeutics to provide better outcomes for patients, advanced tools for clinicians to deliver personalized care, and cost-effective solutions for payers. Biofourmis has a pipeline of products and product candidates across therapeutic areas, including heart failure, acute coronary syndrome, COPD, and chronic pain.
Biovitals TM Analytics Engine is a highly sophisticated personalized physiology-based data analytics platform. Using clinical-grade wearable biosensors and software technology, our AI-empowered health analytics platform, biovitals TM continuously personalizes user experience to optimize engagement and predicts clinical exacerbation days in advanced before a critical event. By providing actionable insights on patients condition, biovitals TM improves quality of life of patients and predicts and prevent costly medical events for care providers. It is designed to integrate readily available biosensors, monitor patient’s physiology and use advanced AI-based learning algorithms to build personalized health models which predicts patients health deterioration, health improvement or drug/therapy’s utility. Our lead product, BiovitalsHF TM , is the first digital therapeutics which utilizes software (along with wearable biosensor(s), adjunctive pharmacotherapy and live clinical support) to manage patients suffering from heart failure.